Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial.

N Yuksel1, S R Majumdar, C Biggs

  • 1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 3126 Dentistry/Pharmacy Centre, Edmonton, AB, T6G 2N8, Canada. nyuksel@pharmacy.ualberta.ca

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
|June 6, 2009
PubMed
Summary

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Surgery Forum.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Brief trauma therapy for occupational trauma-related PTSD/CPTSD in UK police.

Occupational medicine (Oxford, England)·2021
Same author

Sensory wellbeing workshops for inpatient and day-care patients with anorexia nervosa.

Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater·2021
Same author

Correction to: A 3i hip fracture liaison service with nurse and physician co-management is cost-effective when implemented as a standard clinical program.

Archives of osteoporosis·2020
Same author

A 3i hip fracture liaison service with nurse and physician co-management is cost-effective when implemented as a standard clinical program.

Archives of osteoporosis·2020
Same author

Implementation of an in-patient hip fracture liaison services to improve initiation of osteoporosis medication use within 1-year of hip fracture: a population-based time series analysis using the RE-AIM framework.

Archives of osteoporosis·2020

Community pharmacist screening programs effectively doubled osteoporosis testing and treatment rates. However, further interventions are needed as many eligible patients still did not receive appropriate care.

Area of Science:

  • Pharmacology and Pharmaceutical Sciences
  • Public Health and Epidemiology

Background:

  • Osteoporosis screening and treatment rates are suboptimal in many populations.
  • Community pharmacists are accessible healthcare providers who can play a role in improving osteoporosis care.

Purpose of the Study:

  • To evaluate the impact of a community pharmacist-led screening and education intervention on osteoporosis testing and treatment.
  • To assess the effectiveness of a multifaceted intervention in increasing bone mineral density (BMD) testing or osteoporosis medication prescriptions.

Main Methods:

  • A randomized controlled trial involving 262 patients meeting BMD testing guidelines.
  • Intervention group received printed materials, education, and quantitative ultrasound, while the control group did not.
  • Primary outcome was a composite of BMD testing or osteoporosis medication prescription within 4 months.

Related Experiment Videos

Main Results:

  • The intervention group showed a significantly higher rate of achieving the primary endpoint (22% vs. 11%, RR 2.1).
  • This increase was primarily driven by a higher rate of BMD testing in the intervention group (22% vs. 10%).
  • Calcium intake also increased significantly more in the intervention group.

Conclusions:

  • A community pharmacist screening program can effectively double osteoporosis testing rates.
  • Despite the intervention's success, a significant number of eligible patients did not receive appropriate care, indicating a need for more intensive strategies.
  • Pharmacist-led interventions show promise in improving osteoporosis management within community settings.